7
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Systemic rheumatoid vasculitis (SRV) is a rare but potentially serious systemic disease manifestation of rheumatoid arthritis (RA) characterized by the development of necrotizing vasculitis. The incidence of SRV appears to be decreasing possibly reflecting progress in RA treatment. The aims of this study were to review the clinical manifestations of SRV in a stable well-defined population during 2001-10 and to compare with our previous cohort (1988-2000) and also a cohort from 1975 to 1981.

          Related collections

          Author and article information

          Journal
          Rheumatology (Oxford)
          Rheumatology (Oxford, England)
          1462-0332
          1462-0324
          Jan 2014
          : 53
          : 1
          Affiliations
          [1 ] Clinical Teaching Fellows Office, UCL Medical School, Room GF/664, Royal Free Hospital, Hampstead, London NW3 2PF, UK. ntatsakie@doctors.org.uk.
          Article
          ket326
          10.1093/rheumatology/ket326
          24108586
          5f1afeb0-e69a-4956-8106-b8226f4b0d14
          History

          biological therapies,epidemiology,extra-articular manifestations,immunosuppressants,rheumatoid arthritis,systemic rheumatoid vasculitis,vasculitis

          Comments

          Comment on this article